Nebenwirkungen · Busulfan Fresenius Kabi
Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 13
HOS-130035 · Präparat HOS-096825
Hepato-biliary Veno occlusive liver disease Jaundice disorders Liver disorders Skin and Rash subcutaneous tissue disorders Renal and urinary Haemorrhagic cystitis** Renal disorder Oliguria disorders General disorders Asthenia and administration Mucositis Oedema site conditions Pain Investigations Transaminases increased Creatinine elevated Blood lactate Bilirubine increased dehydrogenase Alkaline phosphatases increased increased Blood uric acid increased Blood urea increased GGT increased Weight increased * reported in post-marketing experience ** include haemorrhagic cystitis induced by viral infection
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-01T12:05:00Z · SHA-256 803007b850189812dae1406bc9fec1c869aaeaaacf0104c26b1fa84613ab3fe2 · Passage d199f8968761db936f3877e6a01d0854a950e33b55d1b98a602d65467b50d31b · Zeichen 14804–16345 im Abschnitt